FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1724686013> ?p ?o ?g. }

• W1724686013 endingPage "225" @default.
• W1724686013 startingPage "219" @default.
• W1724686013 abstract "Previously, from the plasma of unrelated haemophilia-B patients, we isolated two non-functional Factor IX variants, namely Los Angeles (IXLA) and Long Beach (IXLB). Both variants could be cleaved to yield Factor IXa-like molecules, but were defective in catalysing the cleavage of Factor X (macromolecular substrate) and in binding to antithrombin III (macromolecular inhibitor). In the present study we have identified the mutation of IXLA by amplifying the exons (including flanking regions) as well as the 5′ end of the gene by polymerase-chain-reaction (PCR) method and sequencing the amplified DNA by the dideoxy chain-termination method. Comparison of the normal IX and IXLA sequences revealed only one base substitution (T----C) in exon VIII of IXLA, with a predicted replacement of Ile-397 to Thr in the mature protein. This mutation is the same as found recently for IXLB. The observation that IXLB and IXLA have the same mutation is an unexpected finding, since, on the basis of their ox brain prothrombin time (PT, a test that measures the ability of the variant Factor IX molecules to inhibit the activation of Factor X by Factor VIIa-tissue factor complex), these variants have been classified into two different groups and were thought to be genetically different. Our observation thus suggests that the ox brain PT does not reflect the locus of mutation in the coding region of the variant molecules. However, our analysis suggests that the ox brain PT is related to Factor IX antigen concentration in the patient's plasma. Importantly, although the mutation in IXLA or IXLB protein is in the catalytic domain, purified IXaLA and IXaLB hydrolyse L-tosylarginine methyl ester at rates very similar to that of normal IXa. These data, in conjunction with our recent data on Factor IXBm Lake Elsinore (Ala-390----Val mutant), strengthen a conclusion that the peptide region containing residues 390-397 of normal Factor IXa plays an essential role in macromolecular substrate catalysis and inhibitor binding. However, the two mutations noted thus far in this region do not distort S1 binding site in the Factor IXa enzyme." @default.
• W1724686013 created "2016-06-24" @default.
• W1724686013 creator A5037405297 @default.
• W1724686013 creator A5064068211 @default.
• W1724686013 creator A5068888539 @default.
• W1724686013 creator A5087902857 @default.
• W1724686013 date "1990-01-01" @default.
• W1724686013 modified "2023-10-18" @default.
• W1724686013 title "Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not <scp>l</scp>-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteins" @default.
• W1724686013 cites W137168614 @default.
• W1724686013 cites W140043360 @default.
• W1724686013 cites W1502744283 @default.
• W1724686013 cites W1521441040 @default.
• W1724686013 cites W1532376143 @default.
• W1724686013 cites W1542609899 @default.
• W1724686013 cites W1601687245 @default.
• W1724686013 cites W1604069916 @default.
• W1724686013 cites W175175572 @default.
• W1724686013 cites W193982181 @default.
• W1724686013 cites W1966875441 @default.
• W1724686013 cites W1971784860 @default.
• W1724686013 cites W1976418095 @default.
• W1724686013 cites W1978856226 @default.
• W1724686013 cites W1994013215 @default.
• W1724686013 cites W1996826759 @default.
• W1724686013 cites W2018289835 @default.
• W1724686013 cites W2019435196 @default.
• W1724686013 cites W2032118018 @default.
• W1724686013 cites W2032827914 @default.
• W1724686013 cites W2041349540 @default.
• W1724686013 cites W2041931045 @default.
• W1724686013 cites W204538406 @default.
• W1724686013 cites W2049831508 @default.
• W1724686013 cites W2063181313 @default.
• W1724686013 cites W2067391256 @default.
• W1724686013 cites W2073885175 @default.
• W1724686013 cites W2100837269 @default.
• W1724686013 cites W2111800688 @default.
• W1724686013 cites W2121486050 @default.
• W1724686013 cites W2138270253 @default.
• W1724686013 cites W2154627661 @default.
• W1724686013 cites W215476265 @default.
• W1724686013 cites W2295080980 @default.
• W1724686013 cites W2312067748 @default.
• W1724686013 cites W2329226239 @default.
• W1724686013 cites W2333285502 @default.
• W1724686013 cites W2336344274 @default.
• W1724686013 cites W2337699788 @default.
• W1724686013 cites W2409020234 @default.
• W1724686013 cites W2409842860 @default.
• W1724686013 cites W2417696606 @default.
• W1724686013 cites W5358143 @default.
• W1724686013 cites W70789348 @default.
• W1724686013 cites W97897255 @default.
• W1724686013 doi "https://doi.org/10.1042/bj2650219" @default.
• W1724686013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1136633" @default.
• W1724686013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2105717" @default.
• W1724686013 hasPublicationYear "1990" @default.
• W1724686013 type Work @default.
• W1724686013 sameAs 1724686013 @default.
• W1724686013 citedByCount "22" @default.
• W1724686013 countsByYear W17246860132013 @default.
• W1724686013 countsByYear W17246860132016 @default.
• W1724686013 crossrefType "journal-article" @default.
• W1724686013 hasAuthorship W1724686013A5037405297 @default.
• W1724686013 hasAuthorship W1724686013A5064068211 @default.
• W1724686013 hasAuthorship W1724686013A5068888539 @default.
• W1724686013 hasAuthorship W1724686013A5087902857 @default.
• W1724686013 hasBestOaLocation W17246860132 @default.
• W1724686013 hasConcept C104317684 @default.
• W1724686013 hasConcept C153911025 @default.
• W1724686013 hasConcept C185592680 @default.
• W1724686013 hasConcept C203014093 @default.
• W1724686013 hasConcept C2777292125 @default.
• W1724686013 hasConcept C2777444498 @default.
• W1724686013 hasConcept C2781221834 @default.
• W1724686013 hasConcept C2910886357 @default.
• W1724686013 hasConcept C36823959 @default.
• W1724686013 hasConcept C501734568 @default.
• W1724686013 hasConcept C54355233 @default.
• W1724686013 hasConcept C55493867 @default.
• W1724686013 hasConcept C86803240 @default.
• W1724686013 hasConcept C89560881 @default.
• W1724686013 hasConceptScore W1724686013C104317684 @default.
• W1724686013 hasConceptScore W1724686013C153911025 @default.
• W1724686013 hasConceptScore W1724686013C185592680 @default.
• W1724686013 hasConceptScore W1724686013C203014093 @default.
• W1724686013 hasConceptScore W1724686013C2777292125 @default.
• W1724686013 hasConceptScore W1724686013C2777444498 @default.
• W1724686013 hasConceptScore W1724686013C2781221834 @default.
• W1724686013 hasConceptScore W1724686013C2910886357 @default.
• W1724686013 hasConceptScore W1724686013C36823959 @default.
• W1724686013 hasConceptScore W1724686013C501734568 @default.
• W1724686013 hasConceptScore W1724686013C54355233 @default.
• W1724686013 hasConceptScore W1724686013C55493867 @default.
• W1724686013 hasConceptScore W1724686013C86803240 @default.
• W1724686013 hasConceptScore W1724686013C89560881 @default.
• W1724686013 hasIssue "1" @default.

• next